{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:20:57Z","timestamp":1791901257272,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1245\/s10434-024-15592-3","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:02:06Z","timestamp":1719871326000},"page":"5997-6006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Circulating Exosomal MicroRNA Signature Predicts Peritoneal Metastasis in Patients with Advanced Gastric Cancer"],"prefix":"10.1245","volume":"31","author":[{"given":"Yuma","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3845-457X","authenticated-orcid":false,"given":"Masaaki","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"key":"15592_CR1","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1053\/j.gastro.2015.05.059","volume":"149","author":"P Tan","year":"2015","unstructured":"Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149:1153\u201362.","journal-title":"Gastroenterology"},{"key":"15592_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"15592_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-012-0163-4","volume":"16","author":"A Nashimoto","year":"2013","unstructured":"Nashimoto A, Akazawa K, Isobe Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16:1\u201327.","journal-title":"Gastric Cancer"},{"key":"15592_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/cancers5010048","volume":"5","author":"T Takahashi","year":"2013","unstructured":"Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancers. 2013;5:48\u201363.","journal-title":"Cancers"},{"key":"15592_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer"},{"key":"15592_CR6","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M, et al. Peritoneal carcinomatosis. World J Gastroenterol. 2013;19:6979\u201394.","journal-title":"World J Gastroenterol"},{"key":"15592_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ags3.12060","volume":"2","author":"J Kitayama","year":"2018","unstructured":"Kitayama J, Ishigami H, Yamaguchi H, et al. Treatment of patients with peritoneal metastases from gastric cancer. Ann Gastroenterol Surg. 2018;2:116\u201323.","journal-title":"Ann Gastroenterol Surg"},{"key":"15592_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/14712590902932889","volume":"9","author":"MA Cortez","year":"2009","unstructured":"Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009;9:703\u201311.","journal-title":"Expert Opin Biol Ther"},{"key":"15592_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrc3107","volume":"11","author":"M van Kouwenhove","year":"2011","unstructured":"van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644\u201356.","journal-title":"Nat Rev Cancer"},{"key":"15592_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15592_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1159\/000369750","volume":"35","author":"QX Wang","year":"2015","unstructured":"Wang QX, Zhu YQ, Zhang H, Xiao J. Altered MiRNA expression in gastric cancer: a systematic review and meta-analysis. Cell Physiol Biochem. 2015;35:933\u201344.","journal-title":"Cell Physiol Biochem"},{"key":"15592_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704\u201314.","journal-title":"Nat Rev Genet"},{"key":"15592_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/cgt.2016.77","volume":"24","author":"R Nedaeinia","year":"2017","unstructured":"Nedaeinia R, Manian M, Jazayeri MH, et al. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther. 2017;24:48\u201356.","journal-title":"Cancer Gene Ther"},{"key":"15592_CR14","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"15592_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/gcc.21924","volume":"51","author":"KW Tsai","year":"2012","unstructured":"Tsai KW, Liao YL, Wu CW, et al. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer. 2012;51:394\u2013401.","journal-title":"Genes Chromosomes Cancer"},{"key":"15592_CR16","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3892\/mmr.2012.745","volume":"5","author":"M Wang","year":"2012","unstructured":"Wang M, Gu H, Wang S, et al. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep. 2012;5:1514\u201320.","journal-title":"Mol Med Rep"},{"key":"15592_CR17","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s11033-012-2267-7","volume":"40","author":"A Gorur","year":"2013","unstructured":"Gorur A, Balci Fidanci S, Dogruer Unal N, et al. Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep. 2013;40:2091\u20136.","journal-title":"Mol Biol Rep"},{"key":"15592_CR18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ejca.2010.10.025","volume":"47","author":"R Liu","year":"2011","unstructured":"Liu R, Zhang C, Hu Z, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47:784\u201391.","journal-title":"Eur J Cancer"},{"key":"15592_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2011.10.034","volume":"316","author":"H Liu","year":"2012","unstructured":"Liu H, Zhu L, Liu B, et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012;316:196\u2013203.","journal-title":"Cancer Lett"},{"key":"15592_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033608","volume":"7","author":"MY Song","year":"2012","unstructured":"Song MY, Pan KF, Su HJ, et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS ONE. 2012;7:e33608.","journal-title":"PLoS ONE"},{"issue":"5","key":"15592_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jmoldx.2013.04.004","volume":"15","author":"SY Kim","year":"2013","unstructured":"Kim SY, Jeon TY, Choi CI, et al. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer. J Mol Diagn. 2013;15(5):661\u20139.","journal-title":"J Mol Diagn"},{"key":"15592_CR22","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41416-022-01710-z","volume":"126","author":"Y Wada","year":"2022","unstructured":"Wada Y, Shimada M, Morine Y, et al. A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinoma. Br J Cancer. 2022;126:1196\u2013204.","journal-title":"Br J Cancer"},{"key":"15592_CR23","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1200\/PO.21.00015","volume":"5","author":"Y Wada","year":"2021","unstructured":"Wada Y, Shimada M, Morine Y, et al. Circulating miRNA signature predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer. JCO Precis Oncol. 2021;5:1788\u2013801.","journal-title":"JCO Precis Oncol"},{"key":"15592_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1053\/j.gastro.2021.03.062","volume":"161","author":"Y Wada","year":"2021","unstructured":"Wada Y, Shimada M, Murano T, et al. A liquid biopsy assay for noninvasive identification of lymph node metastases in T1 colorectal cancer. Gastroenterology. 2021;161:151-162.e151.","journal-title":"Gastroenterology"},{"key":"15592_CR25","doi-asserted-by":"publisher","first-page":"42262","DOI":"10.18632\/oncotarget.15040","volume":"8","author":"M Wei","year":"2017","unstructured":"Wei M, Yang T, Chen X, et al. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells. Oncotarget. 2017;8:42262\u201371.","journal-title":"Oncotarget"},{"key":"15592_CR26","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/1873-3468.12722","volume":"591","author":"G Deng","year":"2017","unstructured":"Deng G, Qu J, Zhang Y, et al. Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier. FEBS Lett. 2017;591:2167\u201379.","journal-title":"FEBS Lett"},{"key":"15592_CR27","first-page":"1081","volume":"43","author":"H Ohzawa","year":"2020","unstructured":"Ohzawa H, Saito A, Kumagai Y, et al. Reduced expression of exosomal miR-29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement. Oncol Rep. 2020;43:1081\u20138.","journal-title":"Oncol Rep"},{"key":"15592_CR28","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41419-021-03803-8","volume":"12","author":"Q He","year":"2021","unstructured":"He Q, Ye A, Ye W, et al. Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1. Cell Death Dis. 2021;12:576.","journal-title":"Cell Death Dis"},{"key":"15592_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12885-023-11113-9","volume":"23","author":"Z Wang","year":"2023","unstructured":"Wang Z, Guan W, Ma Y, et al. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt\/\u03b2-catenin signaling pathway. BMC Cancer. 2023;23:668.","journal-title":"BMC Cancer"},{"key":"15592_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/biomedicines9060591","volume":"9","author":"Y Liang","year":"2021","unstructured":"Liang Y, Li S, Tang L. MicroRNA 320, an anti-oncogene target miRNA for cancer therapy. Biomedicines. 2021;9:591.","journal-title":"Biomedicines"},{"key":"15592_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.460","volume":"8","author":"W Wang","year":"2017","unstructured":"Wang W, Zhang L, Wang Y, et al. Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer. Cell Death Dis. 2017;8:e3071.","journal-title":"Cell Death Dis"},{"key":"15592_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1245\/s10434-020-08649-6","volume":"28","author":"B J\u00f3nsd\u00f3ttir","year":"2021","unstructured":"J\u00f3nsd\u00f3ttir B, Lomnytska M, Poromaa IS, Silins I, St\u00e5lberg K. The peritoneal cancer index is a strong predictor of incomplete cytoreductive surgery in ovarian cancer. Ann Surg Oncol. 2021;28:244\u201351.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15592-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15592-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15592-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T14:25:42Z","timestamp":1722867942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15592-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["15592"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15592-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,29]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}